Valuation: Terumo Corporation

Market Cap 3,263B 20.18B 17.7B 16.31B 15.27B 28.64B 1,904B 29.23B 196B 75.87B 941B 75.79B 74.13B P/E 2026
22.9x
P/E 2027 * 19.5x
Enterprise Value 3,401B 21.04B 18.44B 17B 15.92B 29.85B 1,984B 30.47B 204B 79.07B 981B 78.99B 77.26B EV / Sales 2026
2.75x
EV / Sales 2027 * 2.7x
Free-Float
97.07%
Yield 2026
1.42%
Yield 2027 * 1.61%
Manager TitleAgeSince
Chief Executive Officer 62 2024-03-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 2022-03-31
Director/Board Member 63 2019-06-20
Director/Board Member 75 2020-06-24
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%+3.03% - - 20.02B
-1.36%+6.89%-29.76%-13.48% 162B
+2.06%+2.06%-6.12%-7.01% 103B
-0.76%+5.23%-3.75%+52.04% 55.83B
-2.09%-10.31%+49.00%+52.19% 54.05B
+2.24%+11.06%-8.06%-39.07% 41.71B
+0.01%+12.45% - - 31.94B
+0.91%+1.20%-17.80%-43.91% 26.49B
+3.25%+5.50%+58.83%-4.72% 24.48B
+6.96%+7.58%-9.62%+1.69% 20.52B
Average +1.15%+1.70%+4.09%-0.28% 57.83B
Weighted average by Cap. +0.95%+2.27%-5.30%-0.12%

Financials

2026 2027 *
Net sales 1,118B 6.91B 6.06B 5.59B 5.23B 9.81B 652B 10.01B 67.15B 25.99B 322B 25.96B 25.39B 1,236B 7.65B 6.71B 6.18B 5.79B 10.85B 722B 11.08B 74.3B 28.75B 357B 28.72B 28.09B
Net income 137B 846M 742M 684M 640M 1.2B 79.84B 1.23B 8.22B 3.18B 39.46B 3.18B 3.11B 166B 1.02B 898M 827M 775M 1.45B 96.58B 1.48B 9.95B 3.85B 47.73B 3.84B 3.76B
Net Debt 138B 852M 747M 689M 645M 1.21B 80.39B 1.23B 8.28B 3.2B 39.73B 3.2B 3.13B 75.69B 468M 411M 378M 354M 664M 44.17B 678M 4.55B 1.76B 21.83B 1.76B 1.72B
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-